Fusen Pharmaceutical Company Limited (01652.HK)

Fusen Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceuticals and medical devices. The company is headquartered in Nanyang, Henan and currently employs 1,045 full-time employees. The company went IPO on 2018-07-11. The firm's main business is the sales of Shuanghuanglian Oral Solutions, Shuanghuanglian Injections and other pharmaceutical products. The firm is also engaged in the research, production, and sales of various proprietary Chinese medicine and western medicine products for treating cold, fever, cardiovascular diseases and anemia. The firm mainly conducts business in the domestic market.